Ipratropium |
|
|
Ipratropium 3-(3-hydroxy-1-oxo-2-phenylpropoxy)- 8-methyl-8-(1-methylethyl)-, (endo,syn)-(+-)-8-azoniabicyclo(3.2.1)octane CAS number 60205-81-4, 22254-24-6 (bromide) and 66985-17-9 (bromide) ATC code R01AX03 and R03BB01 Chemical formula C20H30NO3 Molecular weight 350.5 or 430.4 (with bromide) Bioavailability ? Metabolism ? Elimination half-life ? Excretion ? Pregnancy category ? Legal status ? Routes of administration ? ...
Wikipedia - [full article]
Ipratropium Clinical Trials
- Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide
ClinicalTrials.gov Identifier: NCT00381589 - Recruiting
Hypersalivation
- A Comparison of Combivent UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg)
ClinicalTrials.gov Identifier: NCT00273962 - Active, not recruiting
Asthma
- Replacement of Nebulised Ipratropium With Inhaled Tiotropium in Stable COPD
ClinicalTrials.gov Identifier: NCT00335621 - Not yet recruiting
Chronic Obstructive Pulmonary Disease
- A Comparison of Levalbuterol Plus Ipratropium With Levalbuterol Alone in the Treatment of Acute Asthma Exacerbation
ClinicalTrials.gov Identifier: NCT00583778 - Recruiting
Asthma
- Effect of Ipratropium on Acute Bronchitis in Subjects Without Underlying Lung Disease
ClinicalTrials.gov Identifier: NCT00371527 - Completed
Bronchitis
- 12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD
ClinicalTrials.gov Identifier: NCT00239473 - Completed
Pulmonary Disease, Chronic Obstructive
- 12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD
ClinicalTrials.gov Identifier: NCT00240435 - Completed
Pulmonary Disease, Chronic Obstructive
- Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With COPD
ClinicalTrials.gov Identifier: NCT00274040 - Completed
Pulmonary Disease, Chronic Obstructive
- Ipratropium Spray for Drooling Saliva in Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00296946 - Completed
Parkinson's Disease
- Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov Identifier: NCT00117182 - Completed
Lung Diseases, Obstructive
- Lung Health Study (LHS) I and III
ClinicalTrials.gov Identifier: NCT00000568 - Completed
Lung Diseases; Lung Diseases, Obstructive; Chronic Obstructive Pulmonary Disease

Not Signed In -


